Article
Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.
Cancer chemotherapy and pharmacology - 1 Jan 1994
Wang L, Yang C P, Horwitz S B, Trail P A, Casazza A M
Abstract excerpt
MA is an orally active PG derivative with an excellent safety profile that is used primarily for the treatment of carcinomas of the breast and endometrium. We investigated the potential application of MA as an MDR-reversal agent using cell culture and human tumor xenograft models. The reversing a...
Topics
- Animals
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms
- Carcinoma
- Chemotherapy, Adjuvant
- Colonic Neoplasms
- Dactinomycin
- Doxorubicin
- Drug Resistance
- Drug Screening Assays, Antitumor
- Female
- Flow Cytometry
